DK1237571T3 - Toscana-virus-nukleinprotein - Google Patents

Toscana-virus-nukleinprotein

Info

Publication number
DK1237571T3
DK1237571T3 DK00987600T DK00987600T DK1237571T3 DK 1237571 T3 DK1237571 T3 DK 1237571T3 DK 00987600 T DK00987600 T DK 00987600T DK 00987600 T DK00987600 T DK 00987600T DK 1237571 T3 DK1237571 T3 DK 1237571T3
Authority
DK
Denmark
Prior art keywords
toscana virus
virus
nukleinprotein
toscana
antigen
Prior art date
Application number
DK00987600T
Other languages
English (en)
Inventor
Maria Grazia Cusi
Marcello Valassina
Pier Egisto Valensin
Original Assignee
Univ Siena
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Siena filed Critical Univ Siena
Application granted granted Critical
Publication of DK1237571T3 publication Critical patent/DK1237571T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/12011—Bunyaviridae
    • C12N2760/12022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/12011—Bunyaviridae
    • C12N2760/12034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK00987600T 1999-12-16 2000-12-18 Toscana-virus-nukleinprotein DK1237571T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9929783.0A GB9929783D0 (en) 1999-12-16 1999-12-16 Toscana virus nucleoprotein
PCT/IB2000/002031 WO2001044288A2 (en) 1999-12-16 2000-12-18 Toscana virus nucleoprotein

Publications (1)

Publication Number Publication Date
DK1237571T3 true DK1237571T3 (da) 2008-01-02

Family

ID=10866464

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00987600T DK1237571T3 (da) 1999-12-16 2000-12-18 Toscana-virus-nukleinprotein

Country Status (10)

Country Link
EP (1) EP1237571B1 (da)
AT (1) ATE374040T1 (da)
AU (1) AU2390101A (da)
CY (1) CY1107607T1 (da)
DE (1) DE60036563T2 (da)
DK (1) DK1237571T3 (da)
ES (1) ES2293934T3 (da)
GB (1) GB9929783D0 (da)
PT (1) PT1237571E (da)
WO (1) WO2001044288A2 (da)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5298423A (en) * 1987-11-25 1994-03-29 The United States Of America As Represented By The Secretary Of The Army Nucleotide sequences encoding the expression of a Hantaan virus nucleocapsid protein and G1 and G2 glycoproteins
ITMI980889A1 (it) * 1998-04-24 1999-10-24 Diesse Diagnostica Nucleoproteina ricombinante del virus toscana

Also Published As

Publication number Publication date
EP1237571B1 (en) 2007-09-26
PT1237571E (pt) 2007-12-31
ATE374040T1 (de) 2007-10-15
WO2001044288A2 (en) 2001-06-21
ES2293934T3 (es) 2008-04-01
GB9929783D0 (en) 2000-02-09
AU2390101A (en) 2001-06-25
CY1107607T1 (el) 2013-03-13
EP1237571A2 (en) 2002-09-11
DE60036563T2 (de) 2008-07-17
DE60036563D1 (de) 2007-11-08
WO2001044288A3 (en) 2002-01-24

Similar Documents

Publication Publication Date Title
MX2008013993A (es) Combinación adyuvante sinergistica de anticuerpo agonista de cd40/interferona tipo 1, conjugados que la contienen y uso de los mismos como un terapeutico para aumentar la inmunidad celular.
WO2006068663A3 (en) Vaccine compositions for treating coronavirus infection
MXPA02012443A (es) Profarmaco en 3'' de 2'-desoxi-beta-l-nucleosidos.
WO2009072767A3 (en) A powerful vaccine composition comprising a lipopeptide and poly i:c as an adjuvant
EA200801798A1 (ru) Виросомоподобные везикулы, содержащие антигены, производные от gp41
UY26724A1 (es) Métodos y composiciones para tratar el virus de la hepatitis c
CY1118521T1 (el) Συνθεση εμβολιου και μεθοδος χρησης αυτου
AU6616301A (en) Modification of hepatitis b core antigen
NO20015073D0 (no) Vaksiner
FR2814958B1 (fr) Composition vaccinale
ATE458496T1 (de) Hiv-vakzine und anwendungsverfahren
WO2005028496A3 (en) Vaccine for treatment and prevention of herpes simplex virus infection
EA200970586A1 (ru) Антитела к цитомегаловирусу человека (hcmv)
DE60039715D1 (de) Hcv-impfstoff zusammensetzungen
GB0105877D0 (en) Use of flavivirus for the expression of protein epitopes and development of new live attenuated vaccine virus to immunize against flavivirus and otherinfecti
ECSP024257A (es) Proteinas antigenas del virus de la enfermedad de la mancha blanca en el camaron y usos de las mismas
WO2007150008A3 (en) Polypeptides from african swine virus as vaccines for preventive and therapeutic use
MX2023009447A (es) Anticuerpos que se unen a metapneumovirus, proteínas antigénicas de metapneumovirus, y usos de los mismos.
WO2004026260A3 (en) Prophylactic and therapeutic hiv aptamers
PL1949913T3 (pl) Immunostymulująca kombinacja do profilaktyki i leczenia wirusowego zapalenia wątroby typu c
DE60036563D1 (de) Nukleoprotein des toscanavirus
MX2007002659A (es) Composicion vacunal contra el virus de la hepatitis c.
BRPI0414073A (pt) método para induzir uma resposta imune contra infecção por rotavìrus a partir de um sorotipo de rotavìrus, e, uso de uma cepa de rotavìrus atenuado de um sorotipo
EA201401044A1 (ru) Модифицированный вирус болезни марека и вакцины на его основе
AR027738A1 (es) Composicion coadyuvante, composiciones de vacunas que incluyen dicha composicion coadyuvante; procedimiento de induccion de inmunorespuestas antigenicas enmamiferos y procedimiento de tratamiento donde se aplican dichas vacunas